{"database": "lobbying", "table": "lobbying_activities", "rows": [[2017836, "286175f5-0489-42b0-b900-71d2aa0838a3", "3T", "ROSE LAW FIRM, A PROFESSIONAL ASSOCIATION", 78870, "THE INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS", 2017, "third_quarter", "PHA", "Legislative efforts related to the implementation of the Food, Drug and Cosmetic Act, and the Drug Quality and Security Act (P.L 113-54). Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 0, 1, "2017-08-11T09:16:31.547000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2017836"], "units": {}, "query_ms": 0.2927290042862296, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}